1. C‐MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide‐dexamethasone in myeloma. (15th April 2020) Authors: Di Bacco, Alessandra; Bahlis, Nizar J.; Munshi, Nikhil C.; Avet‐Loiseau, Hervé; Masszi, Tamás; Viterbo, Luísa; Pour, Ludek; Ganly, Peter; Cavo, Michele; Langer, Christian; Kumar, Shaji K.; Rajkumar, S. Vincent; Keats, Jonathan J.; Berg, Deborah; Lin, Jianchang; Li, Bin; Badola, Sunita; Shen, Lei;... Journal: European journal of haematology Issue: Volume 105:Number 1(2020) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗